Olivier Molinier
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology
- Cancer Research top 5%
- Surgery
- Co-authors
- Aleksandra SzczęsnaTudor–Eliade CiuleanuSaulius CicėnasErzsébet JuhászEmilio EstebanGaëlle KlingelschmittI. MelezínekGiuseppe Giaccone
- Topics
- Lung Cancer Treatments and Mutations (60 papers)Lung Cancer Research Studies (32 papers)Lung Cancer Diagnosis and Treatment (29 papers)
- Journals
- Journal of Clinical OncologyJNCI Journal of the National Cancer InstituteThe Lancet Oncology
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Olivier Molinier
80 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Pulmonary and Respiratory Medicine 2.6k
- Oncology 2.5k
- Molecular Biology 477
- Cancer Research 463
- Surgery 226
Countries citing papers authored by Olivier Molinier
This map shows the geographic impact of Olivier Molinier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Molinier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Molinier more than expected).
Fields of papers citing papers by Olivier Molinier
This network shows the impact of papers produced by Olivier Molinier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Molinier. The network helps show where Olivier Molinier may publish in the future.
Co-authorship network of co-authors of Olivier Molinier
This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Molinier. A scholar is included among the top collaborators of Olivier Molinier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Molinier. Olivier Molinier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 6 | |
| 6 | 9 | |
| 7 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Studybreakdown → | 165 |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 40 | |
| 11 | 15 | |
| 12 | 19 | |
| 13 | 8 | |
| 14 | 12 | |
| 15 | 31 | |
| 16 | 7 | |
| 17 | 1 | |
| 18 | 1 | |
| 19 | Efficacy and safety of necitumumab continuation therapy in phase 3 SQUIRE study | 1 |
| 20 | 8 |
About Olivier Molinier
Olivier Molinier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 87 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (60 papers), Lung Cancer Research Studies (32 papers) and Lung Cancer Diagnosis and Treatment (29 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.6k citations) and Cancer Research (463 citations). Olivier Molinier has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Aleksandra Szczęsna, Tudor–Eliade Ciuleanu, Saulius Cicėnas, Erzsébet Juhász, Emilio Esteban, Gaëlle Klingelschmitt, I. Melezínek, Giuseppe Giaccone, Wolfram Brugger and Federico Cappuzzo. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.